Drug shortage: Carboplatin Injection (CARBOPLATIN, KYXATA)
FDA lists 35 presentations as Current. Availability: Unavailable (12), Limited Availability (8), Available (9). Reason: Demand increase for the drug; Other. Companies: Ingenus Pharmaceuticals LLC, Teyro Labs, Accord Healthcare Inc., Teva Pharmaceuticals USA, Inc., Gland Pharma Limited….
- Published by source
- 2023-04-28
- First seen by Reality Radar
- 2026-10-22
- Last verified
- 2026-10-22
Affected
- Manufacturer
- Ingenus Pharmaceuticals LLC
- Products
- Carboplatin Injection CARBOPLATIN KYXATA
Whether your exact unit is affected depends on the model, serial number and region in the official notice.
What the official notice says
Risk: Current — Unavailable
Remedy / actions:
- Discontinuation of the manufacture of the drug
- Wholesaler & Distributor through Marketing partner (Apotex Inc.); Discontinuation of the manufacture of the drug
Is this affecting you?
Add what you own or use and Reality Radar will tell you when official changes match it — with evidence and next steps.
Sources
- openFDA Drug Shortages Tier A · official published 2023-04-28
Evidence ledger
Every piece of evidence we store is appended to a public hash chain, so later edits are detectable. Anyone can re-verify it.
| Entry | Kind | Observed | Evidence hash | Entry hash |
|---|---|---|---|---|
| #852 | new | 2026-10-22 | 3a3878b52c50…5e437f | e90961260429…96f81d |
Chain head: #1076 8ad5adc30b9b…88ce20